Dci Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 23-10-2024
- Paid Up Capital ₹ 2.18 Cr
as on 23-10-2024
- Company Age 48 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.88 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.62 Cr
as on 23-10-2024
- Revenue 2.94%
(FY 2023)
- Profit 111.93%
(FY 2023)
- Ebitda 10.95%
(FY 2023)
- Net Worth 2.78%
(FY 2023)
- Total Assets 31.36%
(FY 2023)
About Dci Pharmaceuticals
The Corporate was formerly known as Dci Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.18 Cr.
The company currently has active open charges totaling ₹11.88 Cr. The company has closed loans amounting to ₹1.62 Cr, as per Ministry of Corporate Affairs (MCA) records.
Krishnakumar Agrawal, Anirudh Agrawal, and Anurag Agrawal serve as directors at the Company.
- CIN/LLPIN
U24231GA1975PTC000251
- Company No.
000251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 1975
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dci Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anirudh Agrawal  | Director | 04-Aug-2011 | Current |
| Krishnakumar Agrawal | Whole-Time Director | 04-Aug-2011 | Current |
| Anurag Agrawal | Director | 04-Aug-2011 | Current |
Financial Performance and Corporate Structure Insights of Dci Pharmaceuticals.
Dci Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.94% increase. The company also saw a substantial improvement in profitability, with a 111.93% increase in profit. The company's net worth moved up by a moderate rise of 2.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dci Pharmaceuticals?
In 2023, Dci Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kayji Real Estate Private Limited.Active 48 years 6 monthsKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Agrawal Minerals (Goa) Private LimitedActive 58 years 1 monthKrishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Aryavaan Pharmaceuticals Private LimitedActive 20 years 2 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Agrawal Medicaments Private LimitedActive 12 years 12 days
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Medizest Pharmaceuticals Private LimitedActive 37 years 5 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
- Tyresoles Goa Private LimitedActive 59 years 6 months
Krishnakumar Agrawal, Anirudh Agrawal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Apr 2023 | ₹5.00 Cr | Open |
Others Creation Date: 10 Jun 2022 | ₹7.00 M | Open |
Goa Urban Co-Operative Bank Ltd. Creation Date: 10 Sep 2001 | ₹0.14 M | Open |
How Many Employees Work at Dci Pharmaceuticals?
Dci Pharmaceuticals has a workforce of 26 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dci Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dci Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
